PRODUCTION METHOD FOR BONE-REGENERATION MATERIAL IMPARTED WITH ANTIMICROBIAL PROPERTIES USING INOSITOL PHOSPHATE, AND ANTIMICROBIAL BONE-REGENERATION MATERIAL PRODUCED BY SAID PRODUCTION METHOD

Abstract

Provided is a bone-regeneration material comprising biodegradable fibers and exhibiting antimicrobial properties at an early stage following surgery, A method for producing a bone-regeneration material having antimicrobial properties and comprising biodegradable fibers, wherein the bone-regeneration material is produced by a step in which the biodegradable fibers are immersed in an inositol phosphate solution, then subsequently immersed in a solution containing silver ions, the biodegradable fibers have an outer diameter of 10-100 m, contain at least 30 wt % or more of a biodegradable resin and 40 wt % or more of calcium compound particles, and some of the calcium compound particles are exposed on the surface of the biodegradable fibers.

Claims

1. A method for producing a bone-regeneration material having antimicrobial properties comprising biodegradable fibers, the method comprising the steps of: immersing the biodegradable fibers in an inositol phosphate solution, wherein outer diameter of the biodegradable fiber is 10 to 100 the biodegradable fiber comprises at least 30 wt % of a biodegradable resin and 40 wt % or more of calcium compound particles, and a portion of the calcium compound particles is exposed on a surface of the biodegradable fiber, and immersing the biodegradable fibers in a solution containing silver ions.

2. The method for producing a bone regeneration material having antimicrobial properties according to claim 1, wherein the biodegradable resin is a PLLA resin.

3. The method for producing a bone regeneration material having antimicrobial properties according to claim 1, wherein the biodegradable resin is a PLGA resin.

4. The method for producing a bone regeneration material having antimicrobial properties according to claim 1, wherein the calcium compound particles are -phase tricalcium phosphate particles having outer diameter of 1 to 4 m.

5. The method for producing a material for bone regeneration having antimicrobial properties according to claim 1, wherein the calcium compound particles comprises calcium carbonate or calcium phosphate.

6. The method for producing a bone regeneration material having antimicrobial properties according to claim 1, wherein the bone regeneration material containing the biodegradable fibers is formed in a cotton like shape.

7. A bone regeneration material having antimicrobial properties comprising biodegradable fibers, the biodegradable fibers having outer diameter of 10 to 100 m, containing at least 30 wt % of a biodegradable resin and at least 40 wt % of calcium compound particles, a portion of the calcium compound particles being exposed on a surface of the biodegradable fibers, and silver ions are bound to calcium ions of the calcium compound particles that are exposed on the surface of the biodegradable fibers via inositol phosphate, whereby silver is substantially uniformly distributed and immobilized to the surface of the biodegradable fibers.

8. The bone regeneration material having antimicrobial properties according to claim 7, wherein the biodegradable resin is a PLLA resin.

9. The bone regeneration material having antimicrobial properties according to claim 7, wherein the biodegradable resin is a PLGA resin.

10. The material for bone regeneration having antimicrobial properties according to claim 7, wherein the calcium compound particles comprise calcium carbonate or calcium phosphate.

11. The material for bone regeneration having antimicrobial properties according to claim 7, wherein the calcium compound particles are -phase tricalcium phosphate particles having an outer diameter of 1 to 4 m.

12. The bone regeneration material having antimicrobial properties according to claim 7, wherein the bone regeneration material comprising the biodegradable fibers is formed in a cotton like shape.

13. The material for bone regeneration having antimicrobial properties according to claim 8, wherein the calcium compound particles comprise calcium carbonate or calcium phosphate.

14. The material for bone regeneration having antimicrobial properties according to claim 9, wherein the calcium compound particles comprise calcium carbonate or calcium phosphate.

15. The material for bone regeneration having antimicrobial properties according to claim 8, wherein the calcium compound particles are -phase tricalcium phosphate particles having an outer diameter of 1 to 4 m.

16. The material for bone regeneration having antimicrobial properties according to claim 9, wherein the calcium compound particles are -phase tricalcium phosphate particles having an outer diameter of 1 to 4 m.

17. The material for bone regeneration having antimicrobial properties according to claim 10, wherein the calcium compound particles are -phase tricalcium phosphate particles having an outer diameter of 1 to 4 m.

18. The bone regeneration material having antimicrobial properties according to claim 8, wherein the bone regeneration material comprising the biodegradable fibers is formed in a cotton like shape.

19. The bone regeneration material having antimicrobial properties according to claim 9, wherein the bone regeneration material comprising the biodegradable fibers is formed in a cotton like shape.

20. The bone regeneration material having antimicrobial properties according to claim 10, wherein the bone regeneration material comprising the biodegradable fibers is formed in a cotton like shape.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0024] FIG. 1 Appearance photograph of the silver-bearing bone regenerating material of the present invention

[0025] FIG. 2 Conceptual diagram of biodegradable fibers constituting the silver-bearing bone regenerating material of the present invention

[0026] FIG. 3 A method for producing a material for regenerating silver-bearing bone according to the present invention

[0027] FIG. 4 Scanning Electron Microscopy (SEM) Observation Results of the Silver-Supported Bone Regeneration Material of the present invention

[0028] FIG. 5 Elemental mapping by energy-dispersive X-ray spectroscopy (EDX) of silver-bearing bone regeneration materials of the present invention

[0029] FIG. 6 Elemental analysis by energy dispersive X-ray spectroscopy (EDX) of silver-bearing bone regeneration materials of the present invention

[0030] FIG. 7 Results of IP6 adsorption experiments on biodegradable fibers of the bone-regenerating materials of the present invention.

[0031] FIG. 8 Method of immobilizing silver ions on bone regenerating material of the present invention

[0032] FIG. 9 Results of immobilization experiments of silver ions from the silver-bearing bone reclaimed material of the present invention

[0033] FIG. 10 Results of elution experiments of silver ions from the silver-bearing bone regeneration material of the present invention

[0034] FIG. 11 Changes over time in the amount of silver ions eluted from the silver-bearing bone regeneration material of the present invention

[0035] FIG. 12 Method for evaluating the relative antimicrobial rate of silver-bearing bone reclaimed material of the present invention by using shake method

[0036] FIG. 13 Anti-viral evaluation of silver-carrying bone regenerating materials of the present invention by the stop circle method

[0037] FIG. 14 Results of antimicrobial evaluation by the inhibition circle method of the silver-bearing bone reclaimed material of the present invention

[0038] FIG. 15 Experimental methods for cytotoxicity tests

[0039] FIG. 16 Results of cytotoxicity tests with the MTT assay

[0040] FIG. 17 Results of cytotoxicity studies

[0041] FIG. 18 Method of conducting animal experiment

[0042] FIG. 19 Photograph of a tibia removed from a rabbit after the implantation period

[0043] FIG. 20 Histological evaluation of animal experiments in which the silver-bearing bone regeneration material of the present invention was implanted in rabbits

[0044] FIG. 21 Histological evaluation of animal experiments in which the silver-bearing bone regeneration material of the present invention was implanted in rabbits

[0045] FIG. 22 Histological evaluation of animal experiments in which the silver-bearing bone regeneration material of the present invention was implanted in rabbits

[0046] FIG. 23 Histological evaluation of animal experiments in which the silver-bearing bone regeneration material of the present invention was implanted in rabbits

[0047] FIG. 24 Histological evaluation of animal experiments in which the silver-bearing bone regeneration material of the present invention was implanted in rabbits

[0048] FIG. 25 Histological evaluation of animal experiments in which the silver-bearing bone regeneration material of the present invention was implanted in rabbits

[0049] FIG. 26 CT images of animal experiments in which the silver-bearing bone regeneration material of the present invention was implanted in rabbits

[0050] FIG. 27 CT images of animal experiments in which the silver-bearing bone regeneration material of the present invention was implanted in rabbits

[0051] FIG. 28 CT images of animal experiments in which the silver-bearing bone regeneration material of the present invention was implanted in rabbits

[0052] FIG. 29 Results of an animal experiment in which a material for silver-bearing bone regeneration of the present invention was implanted into a mouse are shown.

[0053] FIG. 30 Results of an animal experiment in which a material for silver-bearing bone regeneration of the present invention was implanted into a mouse are shown.

DETAILED DESCRIPTION OF THE INVENTION

[0054] Hereinafter, embodiments of the present invention will be described with reference to the drawings.

<Biodegradable Fiber>

[0055] The biodegradable fibers of silver-bearing bone regeneration materials of the present invention are produced by spinning polylactic acid or lactic acid-glycolic acid copolymers, such as poly L lactic acid (PLLA) or lactic acid-glycolic acid copolymer (PLGA) as suitable matrix resins using an electrospinning process. In order to allow the calcium compound particles to be contained in a partially exposed state, outer diameter of the fiber is preferably 10 to 100 m, more preferably 20 to 50 m. By spinning in a state in which the calcium compound particles are uniformly dispersed and contained in the spinning solution used in the electrospinning method, the particles of the calcium compound can be uniformly dispersed in the biodegradable fiber. When amount of particles of the calcium compound contained in the biodegradable fiber is 40 to 70% by weight, particles of the calcium compound are exposed on the surface of the fiber.

<Material for Bone Regeneration>

[0056] As the material of silver-bearing bone regenerating material of the present invention, biodegradable fibers spun by an electrospinning method using a spinning solution containing calcium compound particles can be suitably used. Electrospun biodegradable fibers are deposited in a cotton wool like structure on a collector of an electrospinning device and collected to form a cotton wool-like bone regenerating material. The material is manufactured and sold under ReBOSSIS trademark by one of the applicants of the present application, for example, and is widely used in actual clinical practice as a bone defect filler material excellent in handleability for an operator.

<Inositol Phosphate>

[0057] The inositol phosphoric acid used to support silver on the bone regeneration material of the present invention refers to inositol phosphorylated with a hydroxyl group, and includes inositol trisphosphate (IP3 C.sub.6H.sub.15O.sub.15P.sub.3), inositol pentachyphosphoric acid (IP5 C.sub.6H.sub.17O.sub.21P.sub.5), and phytic acid (IP6 c.sub.6H.sub.18O.sub.24P.sub.6). Phytic acid (IP6) is inexpensive and has the largest number of hydroxyl groups to be chelated, so that it can be used particularly suitably.

<Calcium Compound>

[0058] As the calcium compound used in the bone regeneration material of the present invention, calcium phosphate, calcium carbonate, and silicon eluting calcium carbonate are suitably used. -phase tricalcium phosphate (-TCP) is particularly preferred in terms of osteogenic potential. It is preferable that the size of the calcium compound particles is 1 to 4 m in order to contain the calcium compound particles in a biodegradable fiber in a state in which a part of the particles is exposed on the surface of the fiber.

Embodiments of Present Invention

[0059] FIG. 1 is a photograph showing the appearance of a material for regenerating bone in a cotton wool like state, which is a preferred embodiment of the present invention. FIG. 2 is a conceptual diagram of biodegradable fibers constituting a silver-bearing bone regeneration material according to an embodiment of the present invention.

[0060] Referring to FIG. 2, a biodegradable fiber 1 of silver-bearing bone regeneration material of the present invention includes calcium compound particles 2 in a matrix resin 5, and calcium compound particles 2 are partially exposed on the surface of the biodegradable fiber 1. The calcium ion (Ca.sup.2+) and the silver ion 4 (Ag.sup.+) of the calcium compound particles 2 are cross-linked by a chelating bond with a hydroxyl group (OH.sup.) of inositol phosphate 3.

[0061] When the bone regenerating material of the present invention is implanted into a body, the biodegradable fiber 1 is dissolved over time, resulting in release of inositol phosphate 3. When silver ion 4 is dissolved in a state that it is chelate bonded with inositol phosphate 3 in the presence of calcium ions, bonding between inositol phosphate and silver is cut and silver ion 4 is replaced with calcium ion, because chelate of inositol phosphate 3 is more stable (chelating stability is higher) when it is bonded with Ca.sup.2+ than when it is bonded with Ag.sup.+. As a result, silver ion is eluted and exerts an antimicrobial effect.

[0062] FIG. 3 illustrates a method of producing a silver-bearing bone regeneration material according to an embodiment of the present invention. A predetermined amount of weighed fluffy bone-regenerating material is transferred to 6 well plates, to which 1000 ppm of an aqueous solution of phytic acid (pH 7; 6 ml) was added, and incubated at 37 C. for 24 hours. Thereafter, the solution was washed five times with the same volume of pure water, then immersed in an aqueous silver nitrate solution (0 to 20 mM; 6 mL) at a predetermined concentration, washed five times with the same volume of pure water, and air-dried.

[0063] FIG. 4 shows a scanning electron micrograph of the microstructure of the silver-bearing bone regeneration material produced according to the procedure described above. FIG. 5 shows elemental mapping by energy dispersive X-ray spectroscopy (EDX) of the silver-bearing bone regeneration material. FIG. 6 shows the result of confirming the presence of silver ions in the silver-bearing bone regeneration material by elemental analysis of EDX. From the results of the microstructure, elemental mapping, and elemental analysis of the silver-bearing bone regeneration material shown in these figures, it can be seen that the surface structure of the bone regeneration material hardly changes even after the silver ions are immobilized. In addition, it is clear from the EDX analysis of the distribution of elements in the field of view that calcium, phosphorus, and silver are distributed in a distribution corresponding to the fiber shape.

[0064] When a biodegradable fiber is immersed in an aqueous silver nitrate solution, a negatively charged functional group (carboxyl group, carbonyl group, or the like) of the biodegradable resin is bonded to Ag.sup.+ and silver is attached to the surface of the fiber, but since the ionic bond between the silver ion and the functional group of the biodegradable resin is weak, the silver attached to the surface of the resin is not fixed, and is detached by cleaning with pure water. As a result, it is considered that only silver immobilized by chelating with the calcium compound particles via phytic acid remains on the surface of the biodegradable fiber after washing.

Experiment

<Adsorption of Inositol Phosphate to Biodegradable Fibers>

[0065] 6 well plate was loaded with 0.15 g samples of fluffy bone-regenerating materials (ReBOSSIS PLLA 30 wt %/TCP40 wt %/silicon eluting calcium carbonate 30 wt %) and immersed in 1000 ppm concentration 6 ml IP6 solutions and left for 24 hours at room temperature (or 37 C.) humidified condition. Thereafter, IP6 solution not adsorbed to the fiber was recovered and removed. Phosphate ion concentrations of IP6 solution prior to immersion and the recovered solution were measured by inductively coupled plasma-emission spectroscopy. FIG. 7 shows the results of calculating IP6 adsorbed amounts by the phosphate ion concentrations before and after immersion. As shown in FIG. 7, at 25 C. and room temperature, adsorption of slightly less than 0.04 mmol/g of IP6 was observed. In contrast, at 37 C. humidified conditions, IP6 adsorbed slightly more than 0.04 mmol/g.

<Immobilization of Silver on Biodegradable Fibers by Inositol Phosphate>

[0066] According to the procedures shown in FIG. 8, samples of IP6 adsorbed fluffy bone-regenerating materials (ReBOSSIS) were placed on a 6 well plate, immersed in 5 ml of an aqueous silver nitrate solution (concentrations: 0, 5, 10, 20 mM), and allowed to stand for 20 minutes. Thereafter, an unabsorbed silver nitrate aqueous solution was recovered and removed from the fiber, and the amount of silver adsorbed was measured by ICP. As shown in FIG. 9, the adsorption amount increased as the concentration of the immersed silver nitrate aqueous solution increased.

<Elution of Silver Immobilized by Inositol Phosphate>

[0067] According to the procedures shown in FIG. 8, samples of bone-regenerating materials (ReBOSSIS) loaded with varying amounts of silver (silver nitrate aqueous solution concentrations: 0, 5, 10, 20 mM) using IP6 were immersed in 20 mM HEPES buffer adjusted to pH 7.3 at 37 C. for 24 h (0.01 g/ml), and the eluted amounts of silver ions under neutral conditions were investigated by ICP-AES. The results are shown in FIG. 10. The higher the concentration of silver nitrate, the higher the elution amount of silver ions. The samples treated with 0, 5 and 10 mM had nearly identical amounts of adsorption and elution.

[0068] FIG. 11 shows the results of measurements of silver ion elution over time for samples of bone-regenerating materials (ReBOSSIS) loaded with different amounts of silver (silver nitrate aqueous solution concentrations: 0, 3, 5, 10, 20 mM) according to FIG. 8. The eluted amount was almost constant when any of the samples differing in the amount of silver loaded was immersed in HEPES buffer for more than 6 hours. Since the elution amount of silver ions and the antimicrobial property are deeply dependent on the silver ion concentration, this result shows that the antimicrobial property can be easily controlled by the concentration of the silver nitrate aqueous solution used, and it is considered to be effective for the prevention of infection in the early stage after the operation.

[0069] By selecting the concentration of the silver nitrate aqueous solution within the range examined in this study, the amount of silver loaded per 1 g of bone regeneration material can be controlled from 0 to 50 mg, and it has been revealed that the amount of silver ions loaded increases as the concentration of the immersed silver nitrate aqueous solution increases.

<Antimicrobial Assessment>

[0070] IP6 surface-modified bone regeneration materials (ReBOSSIS) were immersed in an aqueous silver nitrate solution (concentrations 0, 1.25, 2.5, 5.0 mM) to support silver to produce samples IP6_ReBO(0), IP6_ReBO(1.25), IP6_ReB)(2.5), and IP6_ReBO(5.0), and the antimicrobial properties of each sample were evaluated by two methods: the I. Shake method and the II. Inhibition Circle method.

[0071] Antimicrobial Assessment by I. Shake Method

[0072] Medium: LB medium (1, 1/10)

[0073] Samples: LB medium, IP6 surface-modified to silver-loaded

[0074] IP6_ReBO(0)IP6_ReBO(1.25); IP6_ReBO(2.5); IP6_ReBO(5.0)

[0075] Escherichia coli (E. coli)

[0076] Bacterial count: 110 5 cells/tube

[0077] Preparation of Microbial Solution

[0078] 1) Control

[0079] 9 ml of LB culture medium is placed into the 50 ml centrifuge pipe, and a further 1 ml of the fungal solution prepared in 1105 CFU/ml is added to produce the suspension.

[0080] 2) Sample

[0081] Prepare 9 ml of extract, add 1 ml of bacterial suspension prepared at 110 5 CFU/ml, and prepare a suspension.

[0082] Set a 50 ml centrifuge tube filled with a microbial solution in a shaker at 37 C. and start culture. After 24 hours, the bacterial suspension was collected from a 50 ml centrifuge tube and the turbidity was measured using a spectrophotometer. FIG. 12 shows the results of evaluating the antimicrobial properties based on the relationship between the absorbance and the number of bacteria. As shown in FIG. 12, only the sample IP6_ReBO (5.0) exhibited antimicrobial properties under all conditions. From these results, it was found that AgNO3 concentration was 5.0 mM or more, regardless of the concentration of the LB medium, and the LB medium exhibited antimicrobial properties.

II. Antimicrobial Evaluation by the Inhibition Circle Method

[0083] IP6_ReBO(0), IP6_ReBO(1.25) and IP6_ReBO(2.5) of materials for regeneration of fluffy bones (ReBOSSIS),

[0084] 0.15 g of a sample of IP6_ReBO (5.0) was filled into a mold former and pressure-molded to prepare a disc sample piece. After sterilizing the sample pieces, each of the samples was evaluated for antimicrobial properties by using the inhibition circle method.

[0085] Specifically, the aforementioned disc sample pieces were placed on LB-agar medium, to which top agar containing E. coli prepared to be 1106 CFU/plate was overlaid. Antimicrobial properties were evaluated by observing the formation of inhibition circles after 48 hours of incubation at 37 C. and comparing the relative antimicrobial rates (FIG. 13). When the silver ion was not immobilized, that is, when E. coli was cultured on IP6_Rebo (0), the bacteria grew around disc, and the formation of the inhibition circle was not observed. On the other hand, in all of IP6_Rebo (1.25, 2.5, 5.0), colony formation of E. coli was not observed in the periphery of the sample piece, and formation of a blocking circle was observed (FIG. 14).

[0086] In addition, samples IP6_ReBO(5), IP6_ReBO(10), and IP6_ReBO(20) were prepared by immersing in an aqueous silver nitrate solution (concentration: 5.0, 10, 20 mM) to support silver, and the same experiment was conducted, and it was found that although the areas of the blocking bands of samples IP6_ReBO(10) and IP6_ReBO(20) were about the same, the areas were larger than those of IP6_ReBO(5). This result suggests that although the silver ion to be immobilized increases depending on the concentration of the silver nitrate aqueous solution, since the amount of silver ion immobilized reaches the amount of silver ion necessary for the antimicrobial action at a concentration of 10 mM or more of the silver nitrate aqueous solution, even if the silver ion is immobilized further, a large change does not occur in the antimicrobial level.

<Cytotoxicity Assessment>

[0087] FIG. 15 shows the experimental method of the cytotoxicity test. The samples IP6_ReBO(0), IP6_ReBO(1.25), IP6_ReBO(2.5), and IP6_ReBO(5.0) are immersed in the medium for 24 hours so as to be 0.01 g/ml, respectively, and only the supernatant (extract) is collected by centrifugation. FIG. 16 is a graph of the number of cells converted from absorbance by MTT-assay after immersion of the recovered extract on osteoblasts previously prepared on Well.

[0088] FIG. 17 is a result of directly seeding the IP6_ReBO(X) group with osteoblasts, and counting the number of the cells by the hemocytometer plate. According to FIG. 17, it is considered that cytotoxicity occurs at an eluted silver ion concentration of 2.41 ppm or more. Incidentally, this corresponds to about 2.5 mM in the immersed silver nitrate aqueous solution.

Animal Experiment 1

[0089] Animal experiments were performed using samples of silver-loaded bone regeneration materials (ReBOSSIS) using IP6 to evaluate biocompatibility. 4.1 mm diameter defect was made using drills in the right and left paw tibiae of male Japan white rabbits weighing about 3 kilograms and samples (silver-loaded cotton-shaped bone regeneration materials at 0, 5, and 10 mM aqueous silver nitrate concentrations, respectively) were implanted. At the time of implantation, the blood and the sample material which came out at the time of making the defect were mixed and then implanted. The implantation period was 4 weeks, and then number of each was 3 (FIG. 18). Tibia was removed from the rabbits after the implantation period, and each evaluation analysis was performed. FIG. 19 shows a photograph when the embedded sample is taken out. The 10 mM silver-loaded sample was darkened in what appeared to be an implant site. This color is believed to originate from the supported silver. The 0.5 mM silver-loaded samples were found to have been repaired such that implants portion cannot be identified.

[0090] FIGS. 20-25 show histological evaluation by pathological sections. The photograph (bright-field) is shown for each of the following: the left foot Ag(0) carrying of the first individual; the right foot Ag(5) carrying of the first individual; the left foot Ag(5) carrying of the second individual; the right foot Ag(10) carrying of the second individual; the left foot Ag(0) carrying of the third individual; the right foot Ag(0) carrying of the third individual; and the sample implantation section of the right foot Ag(10) carrying the third individual. The sample looked like a black shadow, but good penetration of the new bone in the defect was observed regardless of the loading of silver.

[0091] FIGS. 26-28 show the results of an animal experiment in which 0, 5, and 10 mM silver-bearing samples of the silver-bearing bone regeneration material of the present invention were implanted into rabbits as CT scans. It was confirmed that there was no deleterious effect by silver at all silver loading concentrations, and it was found that the biocompatibility was high.

Animal Experiment 2

[0092] Antimicrobial tests were performed in in vivo environments using models of mouse superficial gluteus infection. Antimicrobial cotton-shaped artificial aggregate (Ag+ion concentration: 0, 1, 5 mM anti-microbe processing) was embedded in shallow gluteal muscles of mouse organisms with light-emitting stapler (MSSA)110 CFU 2 l (each n=5). The luminescence MSSA in the mice on days 1 and 3 after implantation was measured by light imaging (IVIS) and bacterial growth changes in the mice were observed.

[0093] Observation results of bacterial growth changes in mice in animal experiment 2 are shown in FIGS. 29 and 30. In FIGS. 29 and 30, Ag (0, 1, 5 mM) indicates a bone regeneration material in which the fiber of the bone regeneration material in the form shown in FIG. 8 is immersed in a phytic acid (IP6) solution and washed, followed by immersion in a silver nitrate solution having concentrations of 0, 1, and 5 mM and then washing with pure water, so that silver is loaded on the fiber of the bone regeneration material in the amounts in the respective cases.

[0094] FIG. 30 shows result of numbering the light from bacteria described above. 1.6-fold PI (Photon Intensity: bacterial load) was observed from day 1 to day 3 at Ag+ion concentrations of 0 mM (control). On the other hand, bacterial growth was significantly suppressed at 1.34-fold at 1 mM and 0.78-fold at 5 mM (FIG. 29: Photograph (day 3) and FIG. 30 (day 1, day 3)). Antimicrobial tests in In vivo environments revealed that cotton-shaped artificial bones immobilized with Ag+ions with IP6 also showed antimicrobial properties in vivo.

[0095] Although the preferred embodiments for carrying out the present invention have been described above, the present invention is not limited thereto, and various modifications can be made within the scope of Technology idea of the present invention.

Explanation of Codes

[0096] 1. Biodegradable fiber

[0097] 2. Calcium compound particle

[0098] 3. Inositol phosphate

[0099] 4. Silver ion

[0100] 5. Matrix resin